The verified answer
As of Sep 2026, DEPLOY verifies NeuroLutions: 1 model, 2 deployments across 2 regions. 1 source back the record.
CategoryBiometric wearables
Overview
NeuroLutions (now merged into Kandu, Inc.) developed the IpsiHand System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- None on file
Key facts
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →NeuroLutions on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jun 2024. Explore where NeuroLutions's robots are operating, by place and type.
View the full NeuroLutions deployment record →
Relationships
Current leadership (2)
- Leo Petrossian CEOsecondary-verified
- Eric Leuthardt Co-founder & Chief Scientific Officersecondary-verified
Founders (1)
- Eric Leuthardtcofounderno longer at company
Safety record
No incidents on record for NeuroLutions.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- NeuroLutions2 deployments
Recent coverage
NeuroLutions in third-party press
Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- early
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
IpsiHand at United States (multiple hotel chains)
- Deployment verifiedVerifiedJun 1, 2024
IpsiHand at Germany, Europe
Sources (1)
Common questions
What is NeuroLutions?
What does NeuroLutions make?
Is NeuroLutions publicly traded?
Who competes with NeuroLutions?
Who is the CEO of NeuroLutions?
How can I invest in NeuroLutions?
Where is NeuroLutions headquartered?
Who owns NeuroLutions?
Where does NeuroLutions operate robots?
How many robots has NeuroLutions deployed?
Is NeuroLutions a top robotics company?
When was NeuroLutions founded?
Is NeuroLutions safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for NeuroLutions.Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
In the press
Recent coverage mentioning NeuroLutions from third-party publications. Automatically surfaced; not part of the verified registry record.
Kandu Health and Neurolutions Merge to Form Kandu, Inc.
NeuroLutions merged with Kandu Health with 0M financing led by Ally Bridge Group and AMED Ventures
NeuroLutions Receives FDA De Novo Market Authorization for IpsiHand
First FDA-authorized BCI for stroke rehab; IpsiHand translates brain signals from uninjured hemisphere into hand movement
Machine-readable surfaces
- Markdown mirror: /companies/neurolutions.md
- RSS feed: /companies/neurolutions/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/c5677c1a-8c95-438d-9619-849950504010
- Revision history: /companies/neurolutions/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
Video
Learn how to set up and use the Neurolutions IpsiHand in any setting! Want to get your own device? Go to https://neurolutions.com/get-ipsihand
Discover the future of neurorehabilitation with the IpsiHand system! In this captivating video, we delve into the cutting-edge technology that allows stroke pat
Meet Heidi Kraemer, a 18-year-old from Missouri who faced challenges after an arteriovenous malformation rupture at the age of seven. After trying various thera
Follow John Michael, a 24-year-old stroke survivor, and his experience with the groundbreaking Neurolutions IpsiHand system. At just 17 years old, John Michael
Monica, a stroke survivor, shares her experience with the Neurolutions IpsiHand system. Designed to improve arm and hand function after a stroke, the system uti
Discover the remarkable story of Mark Forrest, a stroke survivor who regained control of his hand using the Ypsi Hand, the first FDA-cleared brain-computer inte
Join stroke survivor Deenan, who had a stroke three years ago, affecting her left side. She discusses how using the IpsiHand, a rehabilitation device, has impro
Learn more about the IpsiHand at https://neurolutions.com
Experience the incredible journey of Mark Forrest, a lifelong resident of St. Louis, who defied all odds after suffering a stroke. Initially paralyzed on his ri
Heat Index
Serious50/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
NeuroLutions draws attention at the 25th percentile but verifies reality at the 52nd percentile among biometric robots. Hype Gap -26.7, 21st widest among biometric robots.
6-month trend
Analysis
Clean safety record across 2 verified deployments. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 23, 2026